Prestige Consumer Healthcare Inc. PBH
Prestige Consumer Healthcare Inc. (PBH) earns a Piotroski F-score of 5/9 (mixed financial health), with an Altman Z″ in the safe zone. It does not currently pay a dividend. FY2026 revenue was $1.1B at a 17.5% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -2.52 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Recent analyst actions
| Date | Firm | Rating |
|---|---|---|
| 2026-05-15 | Canaccord Genuity | Buy (main) |
| 2026-05-14 | Oppenheimer | Perform (down) |
| 2026-05-07 | Oppenheimer | Outperform (main) |
| 2026-02-02 | Jefferies | Hold (main) |
| 2025-11-07 | Canaccord Genuity | Buy (main) |
| 2025-10-27 | Jefferies | Hold (main) |
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Smart money · insiders, last 12 months
Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 5/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.089 |
| Retained earnings / assets | 0.5 |
| EBIT / assets | 0.089 |
| Equity / liabilities | 1.175 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| PBH | Prestige Consumer Healthcare Inc. | 5/9 | 4.04 | 12.3 | -4.3% |
| ACAD | ACADIA PHARMACEUTICALS INC | 4/9 | 3.79 | 11.1 | +11.9% |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | 3/9 | -1.18 | — | +432.1% |
| IONS | IONIS PHARMACEUTICALS INC | 3/9 | 1.12 | — | +33.8% |
| NSRX | Nasus Pharma Ltd | 3/9 | -13.82 | — | — |
| INDV | Indivior Pharmaceuticals, Inc. | 4/9 | -0.7 | 24.3 | +4.3% |
| ANIP | ANI PHARMACEUTICALS INC | 6/9 | 3.26 | 24.5 | +43.8% |
About Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under the Debrox brand name. It also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand. It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
FAQ
Is PBH financially healthy?
Prestige Consumer Healthcare Inc.'s Piotroski F-score is 5/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does PBH pay a dividend?
No, Prestige Consumer Healthcare Inc. does not currently pay a dividend.
How profitable is PBH?
In FY2026, Prestige Consumer Healthcare Inc. had a net margin of 17.5% and a return on equity of 10.1%.
Is PBH overvalued or undervalued?
Prestige Consumer Healthcare Inc. trades at about 13.4× trailing earnings — below its 10-year norm (10-year range 4.6×–44.2×, median 17.2×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for PBH?
The average Wall-Street price target for Prestige Consumer Healthcare Inc. is $66.80, about 27.8% above the recent price, from 5 analysts.
Is PBH a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Prestige Consumer Healthcare Inc.: a Piotroski F-score of 5/9, an Altman Z″ in the safe zone, a P/E of about 12.3×. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2026-03-31. Facts plus Stocktoria's own computed scores — not investment advice.